Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.030 |
None |
1.000 |
3 |
|
2003 |
2014 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
2 |
2
|
2017 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2006 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Blood basophil count (lab test)
|
phenotype |
|
Laboratory Procedure
|
272
|
452
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Caffeine related disorders
|
group |
|
Mental or Behavioral Dysfunction
|
360
|
56
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Non-small cell lung cancer stage I
|
disease |
|
Neoplastic Process
|
115
|
1
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
stage, gastric cancer
|
phenotype |
|
Neoplastic Process
|
34
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Intestinal metaplasia
|
phenotype |
|
Disease or Syndrome
|
266
|
24
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Locally Advanced Malignant Neoplasm
|
disease |
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Treatment related acute myeloid leukaemia
|
disease |
|
Neoplastic Process
|
65
|
4
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Thyroid Lymphoma
|
disease |
|
Neoplastic Process
|
20
|
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Progression of non-small cell lung cancer
|
disease |
|
Neoplastic Process
|
151
|
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
B-CELL MALIGNANCY, LOW-GRADE
|
disease |
|
Neoplastic Process
|
350
|
19
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Biliary Tract Carcinoma
|
disease |
|
Neoplastic Process
|
25
|
1
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
757
|
47
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Ciliopathies
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
241
|
7
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
alpha-Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
86
|
37
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
alpha^+^ Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
92
|
16
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
LIMB-MAMMARY SYNDROME
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
120
|
1
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Myasthenic Syndromes, Congenital
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
57
|
40
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2014 |
Congenital Myasthenic Syndromes, Postsynaptic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |